Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from ecancermedicalscience

06:42 EDT 15th August 2018 | BioPortfolio

Here are the most relevant search results for "ecancermedicalscience" found in our extensive news archives from over 250 global news sources.

More Information about ecancermedicalscience on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ecancermedicalscience for you to read. Along with our medical data and news we also list ecancermedicalscience Clinical Trials, which are updated daily. BioPortfolio also has a large database of ecancermedicalscience Companies for you to search.

Showing News Articles 1–25 of 1,000+ from ecancermedicalscience

Wednesday 15th August 2018

Cetuximab RT found to be inferior to standard treatment in HPV oropharyngeal cancer

An interim analysis of data from a randomised clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that treatment with radiation therapy and cetuximab is associated with worse overall and progression-free survival...

Tuesday 14th August 2018

Duke team finds missing immune cells that could fight lethal brain tumours

Glioblastoma brain tumours can have an unusual effect on the body's immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body's defenses. Where the T-cells go has been unclear, even as immunotherapies are...

Researchers uncover a major new vulnerability of childhood leukaemia

Childhood leukaemia is a diagnosis that no family ever wants to endure. While the treatment of most types of leukaemia has improved steadily over the years, a few specific types remain very difficult to treat. One of these is called "mixed lineage...

AI platform identifies personalised drug combinations for myeloma patients

A multidisciplinary team of researchers from the National University of Singapore (NUS) has developed an artificial intelligence (AI) technology platform that could potentially change the way drug combinations are being designed, hence enabling doctors to...

Researchers create specialised delivery methods to help treat cancer

More than 100 years ago, German Nobel laureate Paul Ehrlich popularised the "magic bullet" concept -- a method that clinicians might one day use to target invading microbes without harming other parts of the body. Although chemotherapies have been highly...

Evidence of 'precursor escape' may explain why some women present with advanced ovarian cancer

More than two-thirds of women with ovarian cancer have high-grade serous carcinoma (HGSC). Up to 90 percent of HGSCs are not detected until they are beyond the ovaries or fallopian tubes, at which point it may not be possible to fully remove the...

Friday 10th August 2018

Association of radiation therapy plus lumpectomy in reduced risk of dying in women with DCIS

Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone in women with ductal carcinoma in situ (DCIS), a noninvasive early form of breast cancer. Patients...

Discovery could lead to better treatment for leukaemia

Previous research has revealed that patients with acute myeloid leukaemia who also have a particular mutation in a gene called NPM1 have a higher rate of remission with chemotherapy. About one-third of leukaemia patients possess this favourable mutation,...

Thursday 9th August 2018

Late effects of treatment hinder independence of adult survivors of childhood brain tumors

In the first study of its kind, St. Jude Children's Research Hospital investigators have found that more than half of pediatric central nervous system tumour survivors do not achieve complete independence as adults. The findings, published online today...

Kidney cancer's developmental source revealed

In the first experiment of its kind, scientists have revealed the precise identity of cancer cells of the most common childhood and adult kidney cancers. Researchers from the Wellcome Sanger Institute, the University of Cambridge, University of Newcastle...

Scientists identify genetic marker for gastric cancer prognosis

Although immunotherapy is seen as a very promising treatment for cancer, currently only 20 to 30 percent of patients respond positively. Being able to identify the people most likely to benefit from the costly therapy is a Holy Grail for oncologists. In...

Nuclear gatekeeper could block undruggable prostate cancer targets

Certain molecular drivers of cancer growth are "undruggable" - it's been nearly impossible to develop chemicals that would block their action and prevent cancer growth. Many of these molecules function by passing cancer-promoting information through a...

Common skin cancer can signal increased risk of other cancers

People who develop abnormally frequent cases of a skin cancer known as basal cell carcinoma appear to be at significantly increased risk for the development of other cancers, including blood, breast, colon and prostate cancers, according to a preliminary...

Real life' research model for improvement of personalised immunotherapy in cancer

Researchers from the Netherlands Cancer Institute and others have shown that it is possible to obtain immune cells (so-called killer T cells) from the bloodstream of a cancer patient and expand them in a dish together with a living piece of tumour from...

FDA approves mogamulizumab for mycosis fungoides or Sézary syndrome

The US Food and Drug Administration has approved mogamulizumab for adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy. The approval of mogamulizumab, a CC chemokine...

Arsenic in combination with an existing drug could combat cancer

Investigators have discovered that arsenic in combination with an existing leukaemia drug work together to target a master cancer regulator. The team, led by researchers at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC), is hopeful...

Using big data to predict immunotherapy responses

In the age of Big Data, cancer researchers are discovering new ways to monitor the effectiveness of immunotherapy treatments. Researchers at the Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy developed a new way to use bioinformatics...

Wednesday 8th August 2018

Cancer cells send out 'drones' to battle immune system from afar

Cancer cells are more than a lump of cells growing out of control; they participate in active combat with the immune system for their own survival. Being able to evade the immune system is a hallmark of cancer. Cancer cells release biological "drones"...

Anticancer drugs delivered by a new drug delivery system reduce tumour size

Cancer tissue cells are divided into two major groups: cancer cells and cancer stem cells (CSCs). CSCs are related to cancer progression and dissemination, so it's necessary to eradicate CSCs in order to cure cancer. However, because CSCs are resistant...

Back to the future: breast cancer reprises pathways found in foetal cells

Using just a microscope, Italian surgeon Francesco Durante was struck by the similarities between cells in the most malignant cancers and the embryonic cells of the organ in which the cancer originated. More than a century later, scientists at the Salk...

Discovery of a new tumour suppressor previously thought to be an oncogene

A gene that has for decades been considered a tumour promoter, the PLK1 gene, can also perform the exact opposite function: halting the development of cancer. This finding was made by researchers from the Spanish National Cancer Research Centre (CNIO)...

Tuesday 7th August 2018

New important compounds for targeted and immunotherapies for lung cancer

Dr Rolfo speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about new compounds for targeted therapy and immunotherapy. These include new compounds found in RET, ALK and ROS. He also discusses the new compounds in immunotherapy, one specifically,...

Hot topics in pharmacy practice

Dina Dumercy speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about the information presented about pharmacy work. She firstly outlines some of the important topics covered for pharmacists, including the updates in multiple myeloma. Dina ends by...

Updates from a range of lung cancer studies

Prof Santos speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about updates from key trials in lung cancer. He goes in to detail about the latest results of these studies across a range of therapies.

Large B-cell lymphoma: ZUMA-1 trial

Dr Locke speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about the ZUMA-1 trail for large B-cell lymphoma. He goes into detail about the trial design and results so far, suggesting what this means for the future of the study and the outcomes for...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks